Literature DB >> 24910344

Primary culture of human Schwann and schwannoma cells: improved and simplified protocol.

Sonam Dilwali1, Pratik B Patel2, Daniel S Roberts2, Gina M Basinsky3, Gordon J Harris3, Kevin S Emerick2, Konstantina M Stankovic4.   

Abstract

Primary culture of human Schwann cells (SCs) and vestibular schwannoma (VS) cells are invaluable tools to investigate SC physiology and VS pathobiology, and to devise effective pharmacotherapies against VS, which are sorely needed. However, existing culture protocols, in aiming to create robust, pure cultures, employ methods that can lead to loss of biological characteristics of the original cells, potentially resulting in misleading biological findings. We have developed a minimally manipulative method to culture primary human SC and VS cells, without the use of selective mitogens, toxins, or time-consuming and potentially transformative laboratory techniques. Schwann cell purity was quantified longitudinally using S100 staining in SC cultures derived from the great auricular nerve and VS cultures followed for 7 and 12 weeks, respectively. SC cultures retained approximately ≥85% purity for 2 weeks. VS cultures retained approximately ≥80% purity for the majority of the span of 12 weeks, with maximal purity of 87% at 2 weeks. The VS cultures showed high level of biological similarity (68% on average) to their respective parent tumors, as assessed using a protein array featuring 41 growth factors and receptors. Apoptosis rate in vitro negatively correlated with tumor volume. Our results, obtained using a faster, simplified culturing method than previously utilized, indicate that highly pure, primary human SC and VS cultures can be established with minimal manipulation, reaching maximal purity at 2 weeks of culture. The VS cultures recapitulate the parent tumors' biology to a great degree, making them relevant models to investigate VS pathobiology.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24910344      PMCID: PMC4164296          DOI: 10.1016/j.heares.2014.05.006

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  33 in total

1.  A new method of selecting Schwann cells from adult mouse sciatic nerve.

Authors:  Michael E Pannunzio; I-ming Jou; Andrew Long; Tyler C Wind; Gina Beck; Gary Balian
Journal:  J Neurosci Methods       Date:  2005-06-20       Impact factor: 2.390

2.  ErbB expression, activation, and inhibition with lapatinib and tyrphostin (AG825) in human vestibular schwannomas.

Authors:  Zana K Ahmad; Carrie M Brown; Roberto A Cueva; Allen F Ryan; Joni K Doherty
Journal:  Otol Neurotol       Date:  2011-07       Impact factor: 2.311

3.  Reduced apoptosis rates in human schwannomas.

Authors:  Tamara Utermark; Katherine Kaempchen; Gregor Antoniadis; C Oliver Hanemann
Journal:  Brain Pathol       Date:  2005-01       Impact factor: 6.508

4.  Malignant transformation of acoustic neuroma/vestibular schwannoma 10 years after gamma knife stereotactic radiosurgery.

Authors:  Andreas K Demetriades; Nicholas Saunders; Peter Rose; Cyril Fisher; Jeremy Rowe; Robert Tranter; Carl Hardwidge
Journal:  Skull Base       Date:  2010-09

5.  MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival.

Authors:  Joseph A Cioffi; Wei Ying Yue; Sabrina Mendolia-Loffredo; Kameron R Hansen; P Ashley Wackym; Marlan R Hansen
Journal:  Otol Neurotol       Date:  2010-12       Impact factor: 2.311

6.  Treatment of vestibular schwannoma cells with ErbB inhibitors.

Authors:  Matthew L Bush; Sarah S Burns; Janet Oblinger; Sholpan Davletova; Long-Sheng Chang; D Bradley Welling; Abraham Jacob
Journal:  Otol Neurotol       Date:  2012-02       Impact factor: 2.311

7.  Schwann cell-enriched cultures from adult human peripheral nerve: a technique combining short enzymatic dissociation and treatment with cytosine arabinoside (Ara-C).

Authors:  Diany Calderón-Martínez; Zayra Garavito; Clara Spinel; Hernán Hurtado
Journal:  J Neurosci Methods       Date:  2002-02-15       Impact factor: 2.390

8.  Acoustic neuromas (diagnostic value of testing the function of the trigeminal nerve, the cerebellum and optokinetic nystagmus).

Authors:  J Thomsen; K Zilstorff; M Tos
Journal:  J Laryngol Otol       Date:  1983-09       Impact factor: 1.469

9.  Expression of vascular endothelial growth factor and basic fibroblast growth factor in sporadic vestibular schwannomas correlates to growth characteristics.

Authors:  Dimitrios Koutsimpelas; Tobias Stripf; Ulf R Heinrich; Wolf J Mann; Juergen Brieger
Journal:  Otol Neurotol       Date:  2007-12       Impact factor: 2.311

10.  Surgery for acoustic neurinoma. An analysis of 100 translabyrinthine operations.

Authors:  D G Hardy; R Macfarlane; D Baguley; D A Moffat
Journal:  J Neurosurg       Date:  1989-12       Impact factor: 5.115

View more
  14 in total

1.  Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth.

Authors:  Sonam Dilwali; Martijn C Briët; Shyan-Yuan Kao; Takeshi Fujita; Lukas D Landegger; Michael P Platt; Konstantina M Stankovic
Journal:  Mol Oncol       Date:  2015-03-31       Impact factor: 6.603

2.  A Unified Methodological Framework for Vestibular Schwannoma Research.

Authors:  Lukas D Landegger; Jessica E Sagers; Sonam Dilwali; Takeshi Fujita; Mehmet I Sahin; Konstantina M Stankovic
Journal:  J Vis Exp       Date:  2017-06-20       Impact factor: 1.355

3.  Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells.

Authors:  Sonam Dilwali; Daniel Roberts; Konstantina M Stankovic
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

4.  Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas.

Authors:  Sonam Dilwali; Shyan-Yuan Kao; Takeshi Fujita; Lukas D Landegger; Konstantina M Stankovic
Journal:  Transl Res       Date:  2015-01-07       Impact factor: 7.012

5.  Extracellular vesicles derived from human vestibular schwannomas associated with poor hearing damage cochlear cells.

Authors:  Vitor Y R Soares; Nadia A Atai; Takeshi Fujita; Sonam Dilwali; Sarada Sivaraman; Lukas D Landegger; Fred H Hochberg; Carlos A P C Oliveira; Fayez Bahmad; Xandra O Breakefield; Konstantina M Stankovic
Journal:  Neuro Oncol       Date:  2016-05-18       Impact factor: 12.300

6.  A novel alternative splicing isoform of NF2 identified in human Schwann cells.

Authors:  Fang Su; Zhengguang Zhou; Wen Su; Zishu Wang; Qiong Wu
Journal:  Oncol Lett       Date:  2016-06-08       Impact factor: 2.967

7.  Dedifferentiation of human epidermal melanocytes in vitro by long-term trypsinization.

Authors:  Ren-He Chen; Li Xiao; Ru-Zhi Zhang; Sheng-Yi Wang; Yue Li
Journal:  Cell Tissue Bank       Date:  2020-09-25       Impact factor: 1.522

8.  Sulforaphane, a natural component of broccoli, inhibits vestibular schwannoma growth in vitro and in vivo.

Authors:  Bo Gyung Kim; Takeshi Fujita; Konstantina M Stankovic; D Bradley Welling; In Seok Moon; Jae Young Choi; Jieun Yun; Jong Soon Kang; Jong Dae Lee
Journal:  Sci Rep       Date:  2016-11-02       Impact factor: 4.379

Review 9.  Advances and Future Applications of Augmented Peripheral Nerve Regeneration.

Authors:  Salazar Jones; Howard M Eisenberg; Xiaofeng Jia
Journal:  Int J Mol Sci       Date:  2016-09-07       Impact factor: 5.923

10.  Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma.

Authors:  Jessica E Sagers; Adam S Brown; Sasa Vasilijic; Rebecca M Lewis; Mehmet I Sahin; Lukas D Landegger; Roy H Perlis; Isaac S Kohane; D Bradley Welling; Chirag J Patel; Konstantina M Stankovic
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.